Displaying drugs 2501 - 2525 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Phenylethyl resorcinol | 214.264 C14H14O2 |  | A tyrosinase inhibitor with skin-lightening activity. | Benzene Derivatives / Phenols |
| Phthalylsulfathiazole | 403.43 C17H13N3O5S2 |  | A sulfonamide antibacterial indicated in the treatment of gastrointestinal infections. | Sulfonamides |
| Cinchocaine | 343.4632 C20H29N3O2 |  | An anesthetic used for local or regional anesthesia. | Amides / Analgesics and Anesthetics / Anesthetics for Topical Use / Anesthetics, Local |
| Afatinib | 485.938 C24H25ClFN5O3 |  | An antineoplastic agent used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with non-resistant EGFR mutations or resistance to platinum-based chemotherapy. | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors / Protein Kinase Inhibitors |
| Alogliptin | 339.3916 C18H21N5O2 |  | A dipeptidyl peptidase-4 (DPP-4) inhibitor used to treat hyperglycemia in patients with type 2 diabetes mellitus. | DPP-IV Inhibitors / Incretins |
| NBI-98782 | Not Annotated |  | Not Annotated | Not Annotated |
| Linaclotide | 1526.736 C59H79N15O21S6 |  | A guanylate cyclase-C agonist used to treat different types of constipation, such as irritable bowel syndrome-related constipation, idiopathic constipation, and functional constipation. | Guanylate Cyclase-C Agonist / Guanylyl Cyclase C Agonists |
| Samidorphan | 370.449 C21H26N2O4 |  | A novel opioid-system modulator, similar to naltrexone, that functions primarily as a μ-opioid receptor antagonist in vivo and is used primarily in combination with antipsychotics to reduce their metabolic dysfunction-associated adverse effects. | Diazepines, Oxazepines, Thiazepines and Oxepines |
| Trofinetide | 315.326 C13H21N3O6 |  | A drug used to treat Rett syndrome in children and adults. | Amino Acids / Amino Acids, Acidic / Amino Acids, Dicarboxylic / Amino Acids, Peptides, and Proteins / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (weak) / Cytochrome P-450 Enzyme Inhibitors / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / Peptides / UGT1A9 Inhibitors / UGT2B15 Inhibitors / UGT2B7 Inhibitors |
| Ponesimod | 460.97 C23H25ClN2O4S |  | A sphingosine 1-phosphate receptor modulator indicated to treat relapsing multiple sclerosis. | Selective Immunosuppressants / Sphingosine-1-phosphate (S1P) receptor modulators |
| Quinapril | 438.5161 C25H30N2O5 |  | An ACE inhibitor prodrug used to treat hypertension, congestive heart failure, and slow rate of progression of renal disease. | ACE Inhibitors and Diuretics |
| Naloxegol | 651.794 C34H53NO11 |  | A peripherally-selective opioid antagonist used to treat opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain. | Peripheral Opioid Receptor Antagonists |
| Temozolomide | 194.1508 C6H6N6O2 |  | An alkylating agent used to treat glioblastoma multiforme and refractory anaplastic astrocytoma. | Alkylating Drugs / Antineoplastic Agents, Alkylating |
| Mirtazapine | 265.3529 C17H19N3 |  | A tetracyclic antidepressant used in the treatment of major depression and is used off-label as a drug for insomnia and to increase appetite. | Agents that produce hypertension |
| Tedizolid | 370.344 C17H15FN6O3 |  | An oxazolidinone class antibiotic that inhibits bacterial protein synthesis and is proven to be effective in the treatment of certain Gram-positive bacterial infections. | Anti-Bacterial Agents / Oxazolidinone Antibacterial |
| Tedizolid phosphate | 450.323 C17H16FN6O6P |  | An oxazolidinone class antibiotic that inhibits bacterial protein synthesis and is proven to be effective in the treatment of certain Gram-positive bacterial infections. | Anti-Bacterial Agents / Oxazolidinone Antibacterial |
| Ciprofloxacin | 331.3415 C17H18FN3O3 |  | A second generation fluoroquinolone used to treat various susceptible bacterial infections. | Fluoroquinolones |
| Thenalidine | 286.435 C17H22N2S |  | Withdrawn from the Canadian, US, and UK markets in 1963 due to concerns involving neutropenia. | Antihistamines for Topical Use |
| Benzatropine | 307.4293 C21H25NO |  | An anticholinergic drug used to treat Parkinson's disease (PD) and extrapyramidal symptoms, except tardive dyskinesia. | Ethers of Tropine or Tropine Derivatives |
| Pheniramine | 240.3434 C16H20N2 |  | An antihistamine used to treat allergic rhinitis and pruritus. | Antihistamines for Topical Use |
| Brompheniramine | 319.239 C16H19BrN2 |  | A histamine H1 antagonist used to treat coughs, upper respiratory symptoms, and nasal congestion associated with allergies and the common cold. | Substituted Alkylamines |
| Phensuximide | 189.2105 C11H11NO2 |  | For the treatment of epilepsy. | Succinimide Derivatives |
| Ethotoin | 204.2252 C11H12N2O2 |  | A hydantoin antiepileptic used to control tonic-clonic and complex partial seizures. | Hydantoins |
| Amodiaquine | 355.861 C20H22ClN3O |  | An antimalarial drug. | Aminoquinolines |
| Propoxycaine | 294.395 C16H26N2O3 |  | Propoxycaine is a local anesthetic medication. It was used beginning in the 1950s during dental procedures . It has been combined with procaine to accelerate its onset of action and... | Anesthetics, Local / Hydroxybenzoate Ethers / para-Aminobenzoates |
Displaying drugs 2501 - 2525 of 2785 in total